Arlene Naranjo
- Neurology top 0.2%
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 5%
- Surgery top 10%
- Co-authors
- Wendy B. LondonJulie R. ParkSusan L. CohnJohn M. MarisRochelle BagatellMichael D. HogartyMarguerite T. ParisiBarry L. Shulkin
- Topics
- Neuroblastoma Research and Treatments (93 papers)Cancer, Hypoxia, and Metabolism (38 papers)Cancer therapeutics and mechanisms (29 papers)
- Cited by
- NeurologyCancer ResearchGenetics
- Journals
- JAMAJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Arlene Naranjo
101 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Neurology 2.5k
- Molecular Biology 1.6k
- Cancer Research 1.1k
- Oncology 741
- Surgery 393
Countries citing papers authored by Arlene Naranjo
This map shows the geographic impact of Arlene Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene Naranjo more than expected).
Fields of papers citing papers by Arlene Naranjo
This network shows the impact of papers produced by Arlene Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene Naranjo. The network helps show where Arlene Naranjo may publish in the future.
Co-authorship network of co-authors of Arlene Naranjo
This figure shows the co-authorship network connecting the top 25 collaborators of Arlene Naranjo. A scholar is included among the top collaborators of Arlene Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene Naranjo. Arlene Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 11 | |
| 8 | 7 | |
| 9 | 3 | |
| 10 | 5 | |
| 11 | 132 | |
| 12 | 8 | |
| 13 | 23 | |
| 14 | 3 | |
| 15 | 51 | |
| 16 | 62 | |
| 17 | 95 | |
| 18 | 32 | |
| 19 | 37 | |
| 20 | 55 |
About Arlene Naranjo
Arlene Naranjo is a scholar working on Neurology, Cancer Research and Oncology, having authored 110 papers that have together received 3.4k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (93 papers), Cancer, Hypoxia, and Metabolism (38 papers) and Cancer therapeutics and mechanisms (29 papers). The work is most often cited by research in Neurology (2.5k citations), Cancer Research (1.1k citations) and Genetics (321 citations). Arlene Naranjo has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Wendy B. London, Julie R. Park, Susan L. Cohn, John M. Maris, Rochelle Bagatell, Michael D. Hogarty, Marguerite T. Parisi, Barry L. Shulkin, Katherine K. Matthay and Meredith S. Irwin. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.